Skip to content

Visualmed

Clinical trials summarized as Visual Abstracts

Menu
  • Submit Article
  • About
  • Private Policy
  • Visualmed App for iphone
  • Visualmed App for Android
  • List of Clinical Trials

Category: Endocrinology

Posted onSeptember 27, 2020October 22, 2020Cardiovascular Disease

VERTIS CV Trial: Ertugliflozin Effect on CV Outcomes in Type 2 Diabetes

by admin

VERTIS CV Trial: The SGLT-2 inhibitors are the next generation drugs for type 2 diabetes as well as patients with heart failure. We have seen…

Read More
Posted onMay 2, 2020July 24, 2020Endocrinology

VADT Trial: Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

by admin
Read More
Posted onMay 2, 2020July 24, 2020Endocrinology

VA NEPHRON-D Trial: Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy

by admin
Read More
Posted onMay 2, 2020July 24, 2020Endocrinology

TREAT Trial: Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

by admin
Read More
Posted onMay 2, 2020July 24, 2020Cardiovascular Disease

TECOS Trial: Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

by admin
Read More
Posted onMay 2, 2020July 24, 2020Endocrinology

TABLET Trial: Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception

by admin
Read More
Posted onMay 2, 2020October 23, 2020Cardiovascular Disease

DAPA HF Trial: Dapagliflozin in HFrEF with or without Diabetes

by admin1 Comment on DAPA HF Trial: Dapagliflozin in HFrEF with or without Diabetes

The SGLT-2 inhibitor class drugs were initially developed as diabetic medications. The FDA required all diabetic drugs to showcase CV safety before their approval. This…

Read More
Posted onMay 2, 2020December 23, 2020Cardiovascular Disease

ADVANCE Trial: Intensive Blood Glucose Control and vascular outcomes in Type 2 Diabetes

by admin
Read More

Subscribe via Email

Select list(s)*

 

Loading
Amphibious Theme by TemplatePocket ⋅ Powered by WordPress